Healthy Living

Technology Meets Medical: Using Artificial Intelligence with Parkinson's Disease

Using it for research

Exscientia Ltd., an AI company, teamed up with another UK-based drug company, GlaxoSmithKline, to develop an effective drug for Parkinson’s and other diseases. According to the announcement of Exscientia Ltd. through their page, the company’s artificial intelligence platform combined with GSK’s expertise will be used to discover the molecules that may be the key to develop effective drugs.

Using artificial intelligence on this collaboration may easily step up the company’s research because of its involvement with advanced technology. This may lead to faster progress with research, clinical trials, and drug development.